Benjamin Ackerman

Causal machine learning for predicting treatment outcomes

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors

Abstract 1559: TLR7/8 immune-stimulating antibody conjugates elicit robust myeloid activation leading to enhanced effector function and anti-tumor immunity in pre-clinical models

Sensitivity analyses for effect modifiers not observed in the target population when generalizing treatment effects from a randomized controlled trial: Assumptions, models, effect scales, data scenarios, and implementation details